Self-Limiting. Mental Chemotherapy of Spirilloses (Syphilis, Relaps¬

Total Page:16

File Type:pdf, Size:1020Kb

Self-Limiting. Mental Chemotherapy of Spirilloses (Syphilis, Relaps¬ it produces an acute disease of a relapsing type and is THE USE OF ARSPHENAMIN IN self-limiting. Spironema morsus muris {Spirochaeta morsus- NONSYPHILITIC DISEASES - muris), the organism of rat-bite fever, produces a local MATHEW A. REASONER, M.D. lesion at the point of entrance and passes through the Major, Medical Corps, U. S. Army lymph nodes and invades the blood stream and tissues. AND It produces an acute disease of a relapsing type and is HENRY J. NICHOLS, M.D. self-limiting. Major, Medical Corps, U. S. Army Treponemp. pertenue, Castellani, 1905 {Spirochaeta WASHINGTON, D. C. pertenuis), begins its invasion by a local lesion, invades the blood stream, then localizes and produces surface It has been shown by Bronfenbrenner and Noguchi,1 and occasionally deep lesions. It also and may spread by Akatsu,2 Akatsu and Noguchi3 that the spiro- autoinoculation. It is self-limiting. Yaws is not a chetes, especially those parasitic to the higher animals, congenital disease. have many characteristics to a greater or less degree Treponema pallidum, Schaudinn, 1905, {Spirochaeta in common. This is noted in their to be morphology, pallida), produces at first a local lesion, invades the motility, cultural peculiarities and methods of growth, blood stream and involves all tissues and may be trans¬ their reaction to certain compounds especially those mitted to the next generation. The disease does not sometimes known as spirocheticides, and their thermal tend toward recovery. death point. While between some of the various spe- In considering the effect of arsphenamin in non- cies of spirochetes there is quite a little difference in syphilitic disease, it should be remembered that the morphology, there seems to be a sufficient number of original work which led to the production of ars¬ characteristics in common to justify our placing them in phenamin was done not only with Treponema pallidum a single group. but also with Spironema recurrentis of relapsing The following examples will serve to illustrate grada- fever, Spironema gallinarum of a disease in fowls and tions in pathogenicity: Treponema pertenue of yaws. Ehrlich and Hata's a free first monograph on salvarsan is called "The Experi¬ Spirochaeta plicatilis, Ehrenberg, 1833, living mental organism found in stagnant water. Chemotherapy of Spirilloses (Syphilis, Relaps¬ Cristispira balbiana, Certes, 1882 (Spirochaeta bal- ing Fever, Chicken Spirillosis and Yaws)."4 The favorable action of is to be con¬ bianii), has developed parasitic properties for a cold arsphenamin blooded animal and is found in the of sidered as a group effect due to a chemical affinity crystalline style between the and the vital structure of the oyster. drug the organ¬ ism. It was dentium, Koch, 1887 den- logical to expect that other affinities, to a Treponema (Spirochaeta greater or less would be found others is a found com¬ degree, among tium), ordinarily saprophytic organism of the and in the normal human mouth. It invade spirochetes that when present, they could be monly may demonstrated Erom the but its exact rôle in such invasion is not therapeutically. beginning, damaged tissue, the action of as known. therefore, arsphenamin was studied a effect on diseases rather R. 1906 group spirochetal than from Spironema vincenti, Blanchard, (Spirochaeta the of alone. It has been in is the cause of local lesions on the standpoint syphillis given vincenti), probable almost every pathologic condition to which human flesh human mucous membrane, and it invades the underly¬ is heir, but for effect, its tissues but is not believed to invade the specific proper therapeutic ing regularly field would seem to be limited among dis¬ blood stream. nonsyphilitic eases to those caused and in a few 1874 by spirochetes Spironema recurrentis, Lebert, (Spiroschaudin- instances in lesser degree to certain protozoal and nia recurrentis, Spirochaeta recurrentis), invades the bacterial infections. Favorable results had also been human blood stream but does not local produce lesions, observed in one disease of unknown etiology, in rat- bite fever. the cause the was Read before the joint meeting of the Section on Pharmacology Later, of disease found and Therapeutics and the Section on Dermatology at the Seventy-First to be a An should not be made Annual Session of the American Medical Association, New Orleans, spirochete. attempt April, 1920. to carry the group effect too far as there are appar¬ Because of lack of space, this article is abbreviated in The Journal. some diseases, such as Weil's disease The complete article appears in the Transactions of the Section and in ently spirochetal the author's reprints. A copy of the latter will be sent by the author and yellow fever, in which arsphenamin has no benefi¬ en receipt of a stamped addressed envelop. cial effect. 1. Bronfenbrenner and Noguchi: J. Pharmacol. & Exper. Therap. 4: 333 (March) 1913. 2. Akatsu: Arb. a. d. k. Gsndhtsamte 25: 494, 1907. 4. Ehrlich and Hata: The Experimental Chemotherapy of Spirilloses, 3. Akatsu and Noguchi: J. Exper. Med. 25: 363 (March) 1917. Berlin, Julius Springer, 1910. Downloaded From: http://jama.jamanetwork.com/ by a Northeastern University Libraries User on 05/26/2015 CONSIDERATION OF SPECIAL SPIROCHETAL of 10 per cent, arsphenamin in glycerin. This form of DISEASES treatment is probably more essential in military than Vincent's is a form of in civil practice. Ordinarily, this treatment will suffice ; Angina.—Vincent's angina it if have ulcération of the mucous membrane by a but if fails to control the disease, the lesions produced become it spirochete known as Spironema vincenti (possibly extensive or if serious complications exist, is neo- Spironema buccalis, which has for some reason advisable to give intravenous injections of in become pathogenic), in connection with a fusiform arsphenamin medium-sized dosage. bacillus. The relationship of these two organisms to Pulmonary Spirochetosis; Fetid Spirillar Bronchitis ; the disease has not been entirely worked out, as some Pidmonary Gangrene.—From a number of widely sepa¬ observers attribute the lesions to the fusiform bacillus, rated sources, different observers have described a form Tunnicliff,5 however, an excellent of a of spirochetal lung involvement. From Uganda, Tay¬ gives description 13 phase of the pathology, showing the zone of spirochetes lor describes a condition with pneumonic symptoms in advance of the fusiform bacilli in the affected tissue. and termination by crisis. Loygue, Bonnet and Peyre 14 This disease is ordinarily located in the pharynx, but found many organisms in fourteen of twenty-seven may occasionally involve other portions of the body. grave cases of influenza and in four fatal cases. In In civil practice it is not a very common disease, it one case the spirochetes were also found in the urine. is generally susceptible to treatment with local anti¬ Ribeyro15 describes a prolonged case in Peru. A septics and rarely assumes epidemic form. In the mili¬ series of cases was reported from Egypt by Farrah.16 tary service, conditions are different and this disease Castellani1T found two types of spirochetal pulmonary must receive serious consideration as a cause of con¬ involvement in soldiers of the Italian army, the one siderable invalidism and occasional deaths. Bouty ' lasting only several weeks and appearing as an acute states that Vincent's angina forms from 2 to 3 per bronchitis ; the other as a chronic bronchopneumonia of cent, of throat troubles in the French army in peace months' or years' duration or becoming malignant with times. Recent statistics in a British in France irregular fever, emaciation and death. hospital 18 hemoptysis, show the proportion to be as high as 23 per cent. Violle described a mild type with good prognosis. Campbell and Dyas 7 give a very adequate description Nolf and Spehl19 described a condition which they met of the epidemic among the English soldiers at Bram- during the war, similar to a baronchitis or a broncho¬ and detail the different and forms pneumonia, and always characterized by a fetid breath. shott, England, types 20 of manifestations. They note that syphilitics seem The causative organism is described by Nolf and to react worse to this affection. They advise that in seems very similar to what Noguchi has termed Trep¬ mild cases, any of the numerous recommended applica¬ onema macrodentium. It is also to be found in pul¬ tions will about a cure, but con¬ monary gangrene, which may be a termination of this frequently bring they 20 sider the most useful remedy to be arsenic in the form condition. Nolf states that arsphenamin exercises of arsphenamin or neo-arsphenamin, as a local appli¬ a decidedly curative effect if given early. If delayed, cation. the prognosis is not so favorable, or it may be necessary Tixer and Tobe8 discuss the disease as found to administer repeated doses over a period of several among the French soldiers. They advise various local weeks. In such a case it will be noted that, coincident applications, giving first place to neo-arsphenamin. with the treatment, there is a diminution of the spiro¬ They advise the intravenous administration of neo- chetes and a disappearance of the fetid odor of the arsphenamin when the lesions of stomatitis or angina breath. are particularly extensive or when they are accom¬ Pyorrhea alveolaris.—Little is known of the etiology panied by complications. Bouty ° describes the serious of the several conditions resulting in this disease. In results which may follow the appearance of Vincent's some cases, arsphenamin has a decided effect (which angina in the military service. He recommends the use many not be permanent,) and in others, no results are of neo-arsphenamin either in solution or powder noticeable. Where improvement is shown, the spiro¬ applied locally to the affected portion. Renon and Des- chetes are probably responsible, either primarily or bouis * report a series of cases treated in this same secondarily.
Recommended publications
  • Can Leptospirosis Be Treated Without Any Kind of Medication?
    ISSN: 2573-9565 Research Article Journal of Clinical Review & Case Reports Can Leptospirosis Be Treated Without Any Kind of Medication? Huang W L* *Corresponding author Huang Wei Ling, Rua Homero Pacheco Alves, 1929, Franca, Sao Paulo, Infectologist, general practitioner, nutrition doctor, acupuncturist, 14400-010, Brazil, Tel: (+55 16) 3721-2437; E-mail: weilingmg@gmail.com pain management, Medical Acupuncture and Pain Management Clinic, Franca, Sao Paulo, Brazil Submitted: 16 Apr 2018; Accepted: 23 Apr 2018; Published: 10 May 2018 Abstract Introduction: Leptospirosis is an acute infectious disease caused by pathogenic Leptospira. Spread in a variety of ways, though the digestive tract infection is the main route of infection. As the disease pathogen final position in the kidney, the urine has an important role in the proliferation of the disease spreading [1]. Purpose: The purpose of this study was to show if leptospirosis can be treated without any kind of medication. The methodology used was the presentation of one case report of a woman presenting three days of generalized pain all over her body, especially in her muscles, mainly the calves of her legs, fever, headache and trembling. A blood exam was asked, as well as serology and acupuncture to relieve her symptoms. Findings: she recovered very well after five sessions of Acupuncture once a day. A month later, she came back with the results of her serology: it was positive leptospirosis. Conclusion: In this case, leptospirosis was cured without the use any kind of medication, being acupuncture a good therapeutic option, reducing the necessity of the patient’s admittance into a hospital, minimizing the costs of the treatmentand restoring the patient to a normal life very quickly.
    [Show full text]
  • WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 31/05 (2006.01) A61P 31/02 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (21) International Application Number: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, PCT/CA20 14/000 174 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, 4 March 2014 (04.03.2014) KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (25) Filing Language: English OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (26) Publication Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (30) Priority Data: ZW. 13/790,91 1 8 March 2013 (08.03.2013) US (84) Designated States (unless otherwise indicated, for every (71) Applicant: LABORATOIRE M2 [CA/CA]; 4005-A, rue kind of regional protection available): ARIPO (BW, GH, de la Garlock, Sherbrooke, Quebec J1L 1W9 (CA). GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, (72) Inventors: LEMIRE, Gaetan; 6505, rue de la fougere, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, Sherbrooke, Quebec JIN 3W3 (CA).
    [Show full text]
  • Rat Bite Fever Due to Streptobacillus Moniliformis a CASE TREATED by PENICILLIN by F
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by PubMed Central Rat Bite Fever Due to Streptobacillus Moniliformis A CASE TREATED BY PENICILLIN By F. F. KANE, M.D., M.R.C.P.I., D.P.H. Medical Superintendent, Purdysburn Fever Hospital, Belfast IT is unlikely that rat-bite fever will rver become a public health problem in this country, so the justification for publishing the following case lies rather in its rarity, its interesting course and investigation, and in the response to Penicillin. PRESENT CASE. The patient, D. G., born on 1st January, 1929, is the second child in a family of three sons and one daughter of well-to-do parents. There is nothing of import- ance in the family history or the previous history of the boy. Before his present illness he was in good health, was about 5 feet 9j inches in height, and weighed, in his clothes, about 101 stone. The family are city dwellers. On the afternoon of 18th March, 1944, whilst hiking in a party along a country lane about fifteen miles from Belfast city centre, he was bitten over the terminal phalanx of his right index finger by a rat, which held on until pulled off and killed. The rat was described as looking old and sickly. The wound bled slightly at the time, but with ordinary domestic dressings it healed within a few days. Without missing a day from school and feeling normally well in the interval, the boy became sharply ill at lunch-time on 31st March, i.e., thirteen days after the bite.
    [Show full text]
  • The Consequences of Cook's Hawaiian Contacts on the Local Population
    The Consequences of Cook's Hawaiian Contacts on the Local Population by Peter Pirie Professor of Geography University of Hawaii at MFnoa and Assistant Director, East-West Population Institute The arrival of Captain Cook in Hawaiian waters in 1778 initiated a new and, for the Hawaiians, a calamitous phase in their demographic his- tory: this is beyond dispute. From an insecurely estimated population of c.250,000 Hawaiians in 1778, the population, even of some Hawaiian ancestry, fell to c.84,000 by 1850 and to its nadir of c.37,SOO in 1900. How much of the blame for this tragic episode can be assigned directly to the effect of Cook's contacts with the Hawaiians in 1778-9 and how much was inevitable given the subsequent explosion of interest and contact in the Pacific which Cook's discovery detonated, is a matter about which some controversy may persist. But several writers, including the Hawaiian historian Kamakau, have held Cook culpable (Kamakau, 1961, Ch. VIII, pp. 92-104). As a consequence, Cook's name is held by some in Hawaii in a disrepute not encountered elsewhere in the Pacific region whjch he explored. The journals and other writings which resulted from the two Cook visits refer to the problem of venereal diseases among the crews, to the possibility of their transmission from the newcomers to the Hawaiian population and to the possibility of their previous presence. The aim of this paper will be to test the accuracy and probabilities in- valved in Cook's perception of his expedition's role in this process, but in the light of modern Illndsight.
    [Show full text]
  • Sexually Transmitted Infections Introduction and General Considerations Date Reviewed: July, 2010 Section: 5-10 Page 1 of 13
    Sexually Transmitted Infections Introduction and General Considerations Date Reviewed: July, 2010 Section: 5-10 Page 1 of 13 Background Information The incidence of Sexually Transmitted Infections (STIs) in Saskatchewan has been increasing over the past number of years. This may be due in part to the introduction of testing procedures that are easier to complete and less invasive. In Saskatchewan, the rates for chlamydia have been among the highest in Canada. Refer to http://dsol- smed.phac-aspc.gc.ca/dsol-smed/ndis/c_indp_e.html#c_prov for historical surveillance data collected by Public Health Agency of Canada (PHAC). STIs are transmitted in the context of other social and health challenges; the risk of recurrent exposure and infection are likely unless these underlying issues are dealt with. A holistic assessment of clients assists in identifying these underlying issues and a multidisciplinary team approach is often necessary and should involve other partners such as physicians, addiction services and mental health as required. The regulations of The Health Information Protection Act must be adhered to when involving other partners in the management of individuals or when referring individuals to other agencies. This section highlights some of the general and special considerations that should be kept in mind when conducting STI investigations. It also highlights key points and summarizes the Canadian Guidelines on Sexually Transmitted Infections which can be located at http://www.phac-aspc.gc.ca/std-mts/sti-its/guide-lignesdir-eng.php. Reporting Requirements Index cases must be reported to the Ministry of Health. See Reporting Requirements in the General Information section of this manual for additional information and guidelines.
    [Show full text]
  • Copyrighted Material
    INDEX A American hemorrhagic fevers: Antibiotic action; Drug resistance; Α-dystroglycan, 301 Argentine, 16–17, 35, 279–280; Immune system; specifi c disease Abrus precatorius, 689 Bolivian, 277, 280, 287–288; Antiviral agents: AZT (zidovudine), Acid-fast bacteria, 212 Brazilian, 277, 281; overview of, 13, 32, 38, 48, 340–341, 355, 356; Active Bacterial Core (ABCs) 274, 274–279, 282–286; treatment, blocking synthesis of bacterial surveillance, 240 prevention, surveillance of, 275, RNA, 47; categories of HIV, 356; Active immunization, 465 287–289; Venezuelan, 277, 280–281 dengue fever, DHF, and DSS, 327– Acute glomerulonephritis, 119, 121, 126 Amoeba histolytica, 34 328; description of, 32; HAART, Acute Q fever, 15 Anaplasma phagocytophilum, 36, 76, 77, 48, 356–357, 382; hepatitis C virus Adaptive immunity, 40–42 84, 85, 86, 89, 90, 640–641, 645 (HCV), 391, 402–403; HHV-8 Adenocarcinoma of the lower Anaplasmosis, 552 and KS treatment using, 380–382; esophagus, 167–168 Andes virus, 442 SARS, 466–467. See also Interferons Adenovirus infection, 646–647 Anemia, 176, 528 Arenaviridae, 300 Aedes aegypti mosquito, 318, 322, Angiotensin-converting enzyme 2 Argentine hemorrhagic fever, 16–17, 328–329 (ACE-2), 463–464 35, 279–280 Aedes albopictus mosquito, 318, 322–323 Anopheles mosquitoes, 35, 525, 526, 537 Artemisinin, 535 Age-related immune system defects, Anthrax, 15, 670, 674–676 “Asian Flu” pandemic (type H2N2) 639–640, 642 Antibiotic action, 226, 228–229, 235– [1957], 413 Agglutination, 44 237. See also Antimicrobial agents; Aspergillus fungi,
    [Show full text]
  • Chlamydia Trachomatis Neisseria Gonorrhoeae
    st 21 Expert Committee on Selection and Use of Essential Medicines STI ANTIBIOTICS REVIEW (1) Have all important studies/evidence of which you are aware been included in the application? YES (2) For each of the STIs reviewed in the application, and noting the corresponding updated WHO treatment guidelines, please comment in the table below on the application’s proposal for antibiotics to be included on the EML STI ANTIBIOTICS USED IN WHO AND RECOGNIZED GUIDELINES Chlamydia trachomatis UNCOMPLICATED GENITAL CHLAMYDIA AZITHROMYCIN 1g DOXYCYCLINE 100mg TETRACYCLINE 500mg ERYTHROMYCIN 500mg OFLOXACIN 200mg ANORECTAL CHLAMYDIAL INFECTION DOXYCYCLINE 100mg AZITHROMYCIN 1g GENITAL CHLAMYDIAL INFECTION IN PREGNANT WOMEN AZITHROMYCIN 1g AMOXYCILLIN 500mg ERYTHROMYCIN 500mg LYMPHOGRANULOMA VENEREUM (LGV) DOXYCYCLINE 100mg AZITHROMYCIN 1g OPHTHALMIA NEONATORUM AZITHROMYCIN SUSPENSION ERYTHROMYCIN SUSPENSIONS FOR OCULAR PROPHYLAXIS TETRACYCLINE HYDROCHLORIDE 1% EYE OINTMENT ERYTHROMYCIN 0.5% EYE OINTMENT POVIDONE IODINE 2.5% SOLUTION (water-based) SILVER NITRATE 1% SOLUTION CHLORAMPHENICOL 1% EYE OINTMENT. Neisseria gonorrhoeae GENITAL AND ANORECTAL GONOCOCCAL INFECTIONS CEFTRIAXONE 250 MG IM + AZITHROMYCIN 1g CEFIXIME 400 MG + AZITHROMYCIN 1g SPECTINOMYCIN 2 G IM ou CEFTRIAXONE 250 MG IM ou CEFIXIME 400 MG OROPHARYNGEAL GONOCOCCAL INFECTIONS CEFTRIAXONE 250 MG IM + AZITHROMYCIN 1g CEFIXIME 400 MG + AZITHROMYCIN 1g CEFTRIAXONE 250 MG IM RETREATMENT IN CASE OF FAILURE CEFTRIAXONE 500 mg IM + AZITHROMYCIN 2g CEFIXIME 800 mg + AZITHROMYCIN 2g SPECTINOMYCIN 2 G IM + AZITHROMYCIN 2g GENTAMICIN 240 MG IM + AZITHROMYCIN 2g OPHTALMIA NEONATORUM CEFTRIAXONE 50 MG/KG IM (MAXIMUM 150 MG) KANAMYCIN 25 MG/KG IM (MAXIMUM 75 MG) SPECTINOMYCIN 25 MG/KG IM (MAXIMUM 75 MG) FOR OCULAR PROPHYLAXIS, TETRACYCLINE HYDROCHLORIDE 1% EYE OINTMENT ERYTHROMYCIN 0.5% EYE OINTMENT POVIDONE IODINE 2.5% SOLUTION (water-based) SILVER NITRATE 1% SOLUTION CHLORAMPHENICOL 1% EYE OINTMENT.
    [Show full text]
  • On the Origin of the Human Treponematoses (Pinta, Yaws, Endemic Syphilis and Venereal Syphilis)
    Bull. Org. mond. Sante 1963, Bull. WldHlth Org. 29, 7-41 On the Origin of the Human Treponematoses (Pinta, Yaws, Endemic Syphilis and Venereal Syphilis) C. J. HACKETT, M.D., F.R.C.P.1 A close relationship between the four human treponematoses is suggested by their clinical and epidemiological characteristics and by such limited knowledge ofthe treponemes as there is at present. No treponeme of this group (exceptfor that of the rabbit) is known other than in man, but the human treponemesprobably arose long agofrom an animalinfection. The long period cfinfectiousness ofpinta suggests that it may have been the earliest human treponematosis. It may have been spread throughout the world by about 15 000 B.C., being subsequently isolated in the Americas when the Bering Strait wasflooded. About 10 000 B.C. in the Afro-Asian land mass environmental conditions might have favoured treponeme mutants leading to yaws; from these, about 7000 B.C., endemic syphilis perhaps developed, to give rise to venereal syphilis about 3000 B.C. in south-west Asia as big cities developed there. Towards the end of the fifteenth century A.D. a further mutation may have resulted in a more severe venereal syphilis in Europe which, with European exploration and geo- graphical expansion, was subsequently carried throughout the then treponemally uncom- mitted world. These suggestions find some tentative support in climatic changes which might have influenced the selection of those treponemes which still survive in humid or arid climates. Venereal transmission would presumably remove the treponeme from the direct influence of climate. The author makes a plea for further investigation of many aspects of this subject while this is still possible.
    [Show full text]
  • Laboratory Diagnosis of Sexually Transmitted Infections, Including Human Immunodeficiency Virus
    Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus human immunodeficiency including Laboratory transmitted infections, diagnosis of sexually Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus Editor-in-Chief Magnus Unemo Editors Ronald Ballard, Catherine Ison, David Lewis, Francis Ndowa, Rosanna Peeling For more information, please contact: Department of Reproductive Health and Research World Health Organization Avenue Appia 20, CH-1211 Geneva 27, Switzerland ISBN 978 92 4 150584 0 Fax: +41 22 791 4171 E-mail: reproductivehealth@who.int www.who.int/reproductivehealth 7892419 505840 WHO_STI-HIV_lab_manual_cover_final_spread_revised.indd 1 02/07/2013 14:45 Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus Editor-in-Chief Magnus Unemo Editors Ronald Ballard Catherine Ison David Lewis Francis Ndowa Rosanna Peeling WHO Library Cataloguing-in-Publication Data Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus / edited by Magnus Unemo … [et al]. 1.Sexually transmitted diseases – diagnosis. 2.HIV infections – diagnosis. 3.Diagnostic techniques and procedures. 4.Laboratories. I.Unemo, Magnus. II.Ballard, Ronald. III.Ison, Catherine. IV.Lewis, David. V.Ndowa, Francis. VI.Peeling, Rosanna. VII.World Health Organization. ISBN 978 92 4 150584 0 (NLM classification: WC 503.1) © World Health Organization 2013 All rights reserved. Publications of the World Health Organization are available on the WHO web site (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications – whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO web site (www.who.int/about/licensing/copyright_form/en/index.html).
    [Show full text]
  • The Returning Traveller with Fever
    PG133-138 3/10/05 4:35 PM Page 133 THE TRAVELLER WITH FEVER THE RETURNING TRAVELLER WITH FEVER As numbers of visitors returning from exotic destinations in less developed parts of the world increase, the challenges to the physician grow. Travellers face a number of health risks during their journeys. The majority of incidents are related to trauma or to underly- ing co-morbid disease, most commonly cardiovascular dis- ease. Infectious diseases however are a significant problem and range from the potentially life-threatening, such as malaria, to those that are more mundane, such as travellers’ diarrhoea. This article will focus on the traveller who returns with a suspected infectious disease and will discuss a diag- nostic approach, before describing important syndromes and their common causes. HISTORY LUCILLE BLUMBERG JOHN FREAN Pyrexial illness is a presentation of most travel-associated MB BCh, MMed (Microbiol), MB BCh, MMed (Path), infectious diseases, but many common infections such as DTM&H, DOH, DCH DTM&H, MSc (Med Parasitol) influenza and pneumonia also occur in the tropics or may be Specialist Microbiologist Specialist Microbiologist acquired en route to and from exotic regions. Patients may National Institute for National Institute for also have chronic or recurrent medical problems that are Communicable Diseases and Communicable Diseases and unrelated to their tropical exposure. In approaching a pyrexi- University of the University of the al patient, therefore, a general medical history should elicit Witwatersrand Witwatersrand Johannesburg Johannesburg the presence of underlying conditions, particularly those John Frean qualified at the associated with increased risk of infections such as diabetes, Lucille Blumberg is currently University of the malignancy, HIV infection, splenectomy, and pregnancy.
    [Show full text]
  • Current Opinion in Infectious Diseases Was Launched in 1988
    June 2007, Volume 20, Issue 3,pp.237-344 Editorial introductions vii Editorial introductions. Paediatric and neonatal infections 237 Adverse events following immunization: perception and evidence. Jan Bonhoeffer; Ulrich Heininger 247 Managing congenital syphilis again? The more things change [horizontal ellipsis]. Rana Chakraborty; Suzanne Luck 253 Rotavirus vaccines in developed countries. Jim P Buttery; Carl Kirkwood 259 The burden of influenza in children. Mary Iskander; Robert Booy; Stephen Lambert 264 T cell-based diagnosis of childhood tuberculosis infection. Ajit Lalvani; Kerry A Millington 272 Aseptic meningitis. Bonita E Lee; H Dele Davies Pathogenesis and immune response 278 Herpesviral-bacterial synergy in the pathogenesis of human periodontitis. Jørgen Slots 284 Leptospirosis: pathogenesis, immunity, and diagnosis. Raghavan UM Palaniappan; Subbupoongothai Ramanujam; Yung-Fu Chang 293 Experimental infections with West Nile virus. Richard A Bowen; Nicole M Nemeth 298 The role of superantigens of group A Streptococcus and Staphylococcus aureus in Kawasaki disease. Kousaku Matsubara; Takashi Fukaya 304 Distinction between bacterial and viral infections. Jari Nuutila; Esa-Matti Lilius 311 New concepts in vaccine development in malaria. Bernard N Kanoi; Thomas G Egwang Current World Literature Bibliography 317 Current World Literature. Editorial introductions Current Opinion in Infectious Diseases was launched in 1988. Utah, Dr Stevens com- It is part of a successful series of review journals whose pleted an Infectious Dis- unique format is designed to provide a systematic and ease Fellowship at Brooke critical assessment of the literature as presented in the Army Medical Center in many primary journals. The field of infectious diseases is San Antonio, Texas, and divided into 12 sections that are reviewed once a year.
    [Show full text]
  • Lyme Disease
    Lyme Disease Diagnosis of Lyme disease (B burgdorferi infection) is best made on the basis of a history of exposure to the tick vector or tick environment and clinical findings. Although biopsy with isolation of B burgdorferi in culture is definitive, culture is often impractical and rarely available. Since the sensitivity and specificity of anti-B burgdorferi antibody tests are less than desired, a two-step algorithm has been recommended by the CDC/ASTPHLD Second National Conference on Serologic Diagnosis of Lyme Disease: the first step is performance of either total or immunoglobulin-specific (IgG and IgM) antibody assays using EIA technology; the second step involves measurement of antibodies with the Western blot technology on specimens having a positive or equivocal EIA result. For early stage disease (<1 month duration), IgM Western blot testing is recommended, where as both IgG and IgM testing are recommended for late-stage disease. IgM antibodies may be present within a few weeks of disease onset (early stage); however, IgG antibodies are produced later in the disease. Both IgM and IgG antibodies may persist for many months or years. IgM antibody testing is most sensitive between 1 and 2 months following onset, whereas IgG antibody testing is most sensitive 3 months after onset. Patients who are on antibiotic therapy and who have early stage disease may have low or negative antibody titers. Thus, negative results may indicate lack of infection or lack of seroconversion (due to the time of specimen collection relative to disease onset or to suppression of antibody production subsequent to therapy, etc.) If Lyme disease is still suspected following a negative antibody result, testing a second specimen collected 2 to 4 weeks after the first specimen is recommended.
    [Show full text]